MedPath

Evaluation of the Effectiveness of Hydrocortisone and Dexamethasone in the Management of Patients with Chronic Obstructive Pulmonary Disease Exacerbation.

Phase 3
Conditions
Chronic Obstructive Pulmonary Disease.
Chronic obstructive pulmonary disease, unspecified
J44.9
Registration Number
IRCT20200818048447N1
Lead Sponsor
Yasouj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients over 40 years
Confirmed history (FEV1 / FVC <70%) of COPD or typical history (prolonged smoking and chronic sputum and cough)
Exacerbations of the disease include increased cough, sputum, and shortness of breath

Exclusion Criteria

History of Asthma or Atopy
Consumption Systemic Corticosteroids within the Last Month before Hospitalization
Recent Myocardial Infarction
Not Compensated Acute Heart Failure
Diagnosis of Lobar Pneumonia on X-ray or CT scan of the Lungs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dyspnea. Timepoint: Daily till discharge. Method of measurement: Questionnaire. Patients score from 1 to 10 depending on the severity of dyspnea.;Sputum volume. Timepoint: Daily. Method of measurement: Questionnaire. Patients score from 1 to 10 depending on the sputum volume.;Couph. Timepoint: Daily. Method of measurement: Questionnaire. Patients score from 1 to 10 depending on the severity of couph.;Arterial Oxygen Saturation. Timepoint: Daily. Method of measurement: Pulse Oxymeter Device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath